9 September 2008
EASD diabetes data presentation - (PDF 682 kb)
31 July 2008
Second quarter and half year results
Presentation and scripts
David Brennan, Chief Executive Officer - (PDF)
Simon Lowth, Chief Financial Officer - (PDF)
John Patterson, Executive Director, Development - (PDF)
17 July 2008
Regulatory briefing - (PDF 52 kb)
11 June 2008
Goldman Sachs Healthcare Conference - (PDF 1,663 kb)
11 June 2008
ADA diabetes data presentation - (PDF 734 kb)
8 May 2008
Citigroup SRI meeting
AstraZeneca and the Access Debate - (PDF 374 kb)
Least Developed Countries and Emerging Markets - (PDF 553 kb)
Diseases in the Developing World - (PDF 937 kb)
Clinical Trials - (PDF 1,697 kb)
7 May 2008
AZD6140 webex/teleconference
24 April 2008
Annual General Meeting 2008
Presentation
31 January 2008
Fourth quarter and full year results 2007
Presentation
9 January 2008
JP Morgan 26th Annual Healthcare Conference - (PDF 1,380 kb)
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD
- Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceStock symbol - AZN
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
